SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Director Michael S

REGENERON PHARMACEUTICALS, INC. · 144 filed Oct 30, 2026 at 16:20 ET

At the news

NEUTRALIMPACT 2/10

144 filed Oct 30, 2026 at 16:20 ET

Director Michael S. Brown filed a Form 144 notice of intent to sell 1,929 shares of Regeneron common stock, with an approximate market value of $1.58 million based on the filing date. The shares were acquired through stock option exercises, and the sale is planned for execution on October 30, 2026.

  • Reporting person: Michael S. Brown, a Director of Regeneron Pharmaceuticals, Inc.
  • Proposed sale of 1,929 shares of common stock.
  • Estimated aggregate market value: $1,579,407.33.
  • Shares acquired via exercise of stock options on October 30, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access